Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

Nonalcoholic steatohepatitis (NASH), characterized by liver steatosis, inflammation and injury, has emerged as one of major causes for end-stage liver disease like hepatocellular carcinoma. However, what drives its progression?

25 Aug 2022

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

25 Aug 2022

COVID-19 pandemic: An epidemiological update

Epidemics and pandemics have been frightening the human chase again and again. SARS, H1N1, Ebola, and more have exposed their real face in the past, but with every such outbreak.

25 Aug 2022

SARS-CoV-2 mutational spectra based on reconstructed phylogenetic tree

In a new study, researchers assessed the impact of mutagenesis on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome and the effects of mutations in the neutral regions and non-neutral regions of the genome.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and SARS-CoV-2 infection severity.

25 Aug 2022

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

A recent study investigated ‘targets’ in the poxvirus and identified the protein residues active in MPV, following which eight potential anti-viral drugs were proposed.

25 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting.

24 Aug 2022

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Chemotherapy sucks. The treatments generally have awful side effects, and it's no secret that the drugs involved are often toxic to the patient as well as their cancer.

24 Aug 2022

Study shows how Klebsiella pneumoniae suppresses the body's defenses

New research published in Cell Reports has shown how the bacterium Klebsiella pneumoniae suppresses our body's defences, resulting in it being unable to clear infection.

24 Aug 2022

Changes in brain connections occur very early in Alzheimer's disease

Although a lot is known about brain alterations in symptomatic Alzheimer's disease (AD), less is known about changes in the brain network early in the disease process.

24 Aug 2022

What is the impact of a syntenin inhibitor in COVID-19 treatment?

In a new study, researchers assessed the impact of a syntenin inhibitor on SARS-CoV-2 entry.

24 Aug 2022

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

Around 80% of people with Down syndrome develop Alzheimer's disease, often when they are between 40 and 50 years old.

24 Aug 2022

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

Researchers evaluated how SARS-CoV-2-specific-T lymphocytes induced by infection, vaccination, or both conferred protection against severe COVID-19.

24 Aug 2022

What is the stability of SARS-CoV-2 strains in human biological fluids?

In a new study, researchers assessed the stability of ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage in human biological fluids.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

RCSI research provides greater insight into the causes of Long COVID syndrome

New research from RCSI University of Medicine and Health Sciences has provided greater insight into the causes of Long COVID syndrome.

23 Aug 2022

UCL researchers identify multiple risk factors for a prematurely aging brain

By estimating people's brain age from MRI scans using machine learning, a team led by UCL researchers has identified multiple risk factors for a prematurely ageing brain.

23 Aug 2022

Protein News and Research

Further Reading

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

COVID-19 pandemic: An epidemiological update

SARS-CoV-2 mutational spectra based on reconstructed phylogenetic tree

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

The risk of adverse reactions when herbal medications are taken with cancer drugs

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Study shows how Klebsiella pneumoniae suppresses the body's defenses

Changes in brain connections occur very early in Alzheimer's disease

What is the impact of a syntenin inhibitor in COVID-19 treatment?

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

What is the stability of SARS-CoV-2 strains in human biological fluids?

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

RCSI research provides greater insight into the causes of Long COVID syndrome

UCL researchers identify multiple risk factors for a prematurely aging brain

Industry Focus eBook - Protein Analysis (3rd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo